Koers Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0011042806
Holdingvennootschappen
Omzet 2022 | 370K 99,87K 37 mln. 92,8K | Omzet 2023 | 104K 28,07K 10,4 mln. 26,09K | Marktkapitalisatie | 62,27 mln. 16,81 mln. 6,23 mld. 15,62 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -61 mln. -16,46 mln. -6,1 mld. -15,3 mln. | Nettowinst (verlies) 2023 | -31 mln. -8,37 mln. -3,1 mld. -7,78 mln. | EV/omzet 2022 | 331 x |
Nettoschuld 2022 | 23,85 mln. 6,44 mln. 2,38 mld. 5,98 mln. | Nettoschuld 2023 | 22,4 mln. 6,05 mln. 2,24 mld. 5,62 mln. | EV/omzet 2023 | 814 x |
K/w-verhouding 2022 |
-1,6
x | K/w-verhouding 2023 |
-2,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,41% | 77,36 mld. | |
+64,10% | 18,24 mld. | |
+4,61% | 16,24 mld. | |
+7,02% | 14,06 mld. | |
-0,04% | 12,58 mld. | |
+7,21% | 11,87 mld. | |
+7,38% | 10,99 mld. | |
+33,84% | 10,26 mld. | |
+0,04% | 9,96 mld. |